These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

259 related items for PubMed ID: 14695214

  • 1. Intratumoral immunization with tumor RNA-pulsed dendritic cells confers antitumor immunity in a C57BL/6 pancreatic murine tumor model.
    Schmidt T, Ziske C, Märten A, Endres S, Tiemann K, Schmitz V, Gorschlüter M, Schneider C, Sauerbruch T, Schmidt-Wolf IG.
    Cancer Res; 2003 Dec 15; 63(24):8962-7. PubMed ID: 14695214
    [Abstract] [Full Text] [Related]

  • 2. Dendritic cells pulsed with alpha-galactosylceramide induce anti-tumor immunity against pancreatic cancer in vivo.
    Nagaraj S, Ziske C, Strehl J, Messmer D, Sauerbruch T, Schmidt-Wolf IG.
    Int Immunol; 2006 Aug 15; 18(8):1279-83. PubMed ID: 16772371
    [Abstract] [Full Text] [Related]

  • 3. Enhancement of antitumor immunity of dendritic cells pulsed with heat-treated tumor lysate in murine pancreatic cancer.
    Kim HS, Choo YS, Koo T, Bang S, Oh TY, Wen J, Song SY.
    Immunol Lett; 2006 Mar 15; 103(2):142-8. PubMed ID: 16313973
    [Abstract] [Full Text] [Related]

  • 4. Apoptotic pancreatic tumor cells are superior to cell lysates in promoting cross-priming of cytotoxic T cells and activate NK and gammadelta T cells.
    Schnurr M, Scholz C, Rothenfusser S, Galambos P, Dauer M, Röbe J, Endres S, Eigler A.
    Cancer Res; 2002 Apr 15; 62(8):2347-52. PubMed ID: 11956095
    [Abstract] [Full Text] [Related]

  • 5. Administration of interleukin-12 enhances the therapeutic efficacy of dendritic cell-based tumor vaccines in mouse hepatocellular carcinoma.
    Tatsumi T, Takehara T, Kanto T, Miyagi T, Kuzushita N, Sugimoto Y, Jinushi M, Kasahara A, Sasaki Y, Hori M, Hayashi N.
    Cancer Res; 2001 Oct 15; 61(20):7563-7. PubMed ID: 11606395
    [Abstract] [Full Text] [Related]

  • 6. Adoptive immunotherapy for pancreatic cancer using MUC1 peptide-pulsed dendritic cells and activated T lymphocytes.
    Kondo H, Hazama S, Kawaoka T, Yoshino S, Yoshida S, Tokuno K, Takashima M, Ueno T, Hinoda Y, Oka M.
    Anticancer Res; 2008 Oct 15; 28(1B):379-87. PubMed ID: 18383873
    [Abstract] [Full Text] [Related]

  • 7. Antitumor effect of intratumoral administration of bone marrow-derived dendritic cells transduced with wild-type p53 gene.
    Murakami T, Tokunaga N, Waku T, Gomi S, Kagawa S, Tanaka N, Fujiwara T.
    Clin Cancer Res; 2004 Jun 01; 10(11):3871-80. PubMed ID: 15173096
    [Abstract] [Full Text] [Related]

  • 8. Induction of cytotoxic T lymphocytes by dendritic cells pulsed with murine leukemic cell RNA.
    Jung CW, Kwon JH, Seol JG, Park WH, Hyun JM, Kim ES, Kim ST, Lee SJ, Kim BK, Lee YY.
    Am J Hematol; 2004 Mar 01; 75(3):121-7. PubMed ID: 14978690
    [Abstract] [Full Text] [Related]

  • 9. [Specific immune against pancreatic cancer induced by dendritic cells pulsed with mutant K-ras peptide].
    Yang B, He Y, Sun DL, Zou Y, Qin XH, Huang BH.
    Zhonghua Yi Xue Za Zhi; 2008 Jul 22; 88(28):1956-60. PubMed ID: 19062734
    [Abstract] [Full Text] [Related]

  • 10. [Enhanced translational efficacy of internal ribosomal entry site-mediated mRNA in dendritic cells contributes to efficient induction of antitumor immunity].
    Tan XH, Wan YH.
    Zhonghua Yi Xue Za Zhi; 2007 Feb 06; 87(6):399-403. PubMed ID: 17456382
    [Abstract] [Full Text] [Related]

  • 11. Immunotherapy of intracranial G422 glioblastoma with dendritic cells pulsed with tumor extract or RNA.
    Zhang Z, Tang LL, Zhan RY, Tong Y, Yao HP, Du LA.
    J Zhejiang Univ Sci; 2004 Oct 06; 5(10):1298-303. PubMed ID: 15362204
    [Abstract] [Full Text] [Related]

  • 12. Combined intratumoral injection of bone marrow-derived dendritic cells and systemic chemotherapy to treat pre-existing murine tumors.
    Tong Y, Song W, Crystal RG.
    Cancer Res; 2001 Oct 15; 61(20):7530-5. PubMed ID: 11606390
    [Abstract] [Full Text] [Related]

  • 13. Radiotherapy potentiates the therapeutic efficacy of intratumoral dendritic cell administration.
    Teitz-Tennenbaum S, Li Q, Rynkiewicz S, Ito F, Davis MA, McGinn CJ, Chang AE.
    Cancer Res; 2003 Dec 01; 63(23):8466-75. PubMed ID: 14679011
    [Abstract] [Full Text] [Related]

  • 14. Interferon gamma stimulates cellular maturation of dendritic cell line DC2.4 leading to induction of efficient cytotoxic T cell responses and antitumor immunity.
    He T, Tang C, Xu S, Moyana T, Xiang J.
    Cell Mol Immunol; 2007 Apr 01; 4(2):105-11. PubMed ID: 17484804
    [Abstract] [Full Text] [Related]

  • 15. Enhanced inhibition of tumor growth with depletion of CD25 regulatory cells and intratumoral immunization with tumor RNA-pulsed dendritic cells in a C57BL/6 pancreatic tumor model.
    Linke A, Brossart P, Schmidt-Wolf IG, Gonzalez-Carmona MA, Ziske C, Messmer D, Schmitz V, Sauerbruch T.
    Pancreas; 2009 Jul 01; 38(5):602-4. PubMed ID: 19550282
    [No Abstract] [Full Text] [Related]

  • 16. Expression of toll-like receptor 4 on dendritic cells is significant for anticancer effect of dendritic cell-based immunotherapy in combination with an active component of OK-432, a streptococcal preparation.
    Okamoto M, Furuichi S, Nishioka Y, Oshikawa T, Tano T, Ahmed SU, Takeda K, Akira S, Ryoma Y, Moriya Y, Saito M, Sone S, Sato M.
    Cancer Res; 2004 Aug 01; 64(15):5461-70. PubMed ID: 15289356
    [Abstract] [Full Text] [Related]

  • 17. Enhanced cancer immunotherapy using STAT3-depleted dendritic cells with high Th1-inducing ability and resistance to cancer cell-derived inhibitory factors.
    Iwata-Kajihara T, Sumimoto H, Kawamura N, Ueda R, Takahashi T, Mizuguchi H, Miyagishi M, Takeda K, Kawakami Y.
    J Immunol; 2011 Jul 01; 187(1):27-36. PubMed ID: 21632716
    [Abstract] [Full Text] [Related]

  • 18. [Therapeutic effects of treatment of pancreatic carcinoma by interleukin-23 and apoptotic cell antigen-modified dendritic cell vaccine: experiment with mice].
    Tan G, Wang ZY, Yin S.
    Zhonghua Yi Xue Za Zhi; 2006 Apr 11; 86(14):943-6. PubMed ID: 16759530
    [Abstract] [Full Text] [Related]

  • 19. Dendritic cell-tumor cell hybrids enhance the induction of cytotoxic T lymphocytes against murine colon cancer: a comparative analysis of antigen loading methods for the vaccination of immunotherapeutic dendritic cells.
    Yasuda T, Kamigaki T, Nakamura T, Imanishi T, Hayashi S, Kawasaki K, Takase S, Ajiki T, Kuroda Y.
    Oncol Rep; 2006 Dec 11; 16(6):1317-24. PubMed ID: 17089056
    [Abstract] [Full Text] [Related]

  • 20. T cell-dependent antitumor immunity mediated by secondary lymphoid tissue chemokine: augmentation of dendritic cell-based immunotherapy.
    Kirk CJ, Hartigan-O'Connor D, Nickoloff BJ, Chamberlain JS, Giedlin M, Aukerman L, Mule JJ.
    Cancer Res; 2001 Mar 01; 61(5):2062-70. PubMed ID: 11280767
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.